199 related articles for article (PubMed ID: 25099282)
1. Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour.
Hanks S; Perdeaux ER; Seal S; Ruark E; Mahamdallie SS; Murray A; Ramsay E; Del Vecchio Duarte S; Zachariou A; de Souza B; Warren-Perry M; Elliott A; Davidson A; Price H; Stiller C; Pritchard-Jones K; Rahman N
Nat Commun; 2014 Aug; 5():4398. PubMed ID: 25099282
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel CTR9 germline mutation in a family with Wilms tumor.
Martins AG; Pinto AT; Domingues R; Cavaco BM
Eur J Med Genet; 2018 May; 61(5):294-299. PubMed ID: 29292210
[TBL] [Abstract][Full Text] [Related]
3. TRIM28 haploinsufficiency predisposes to Wilms tumor.
Diets IJ; Hoyer J; Ekici AB; Popp B; Hoogerbrugge N; van Reijmersdal SV; Bhaskaran R; Hadjihannas M; Vasileiou G; Thiel CT; Seven D; Uebe S; Ilencikova D; Waanders E; Mavinkurve-Groothuis AMC; Roeleveld N; de Krijger RR; Wegert J; Graf N; Vokuhl C; Agaimy A; Gessler M; Reis A; Kuiper RP; Jongmans MCJ; Metzler M
Int J Cancer; 2019 Aug; 145(4):941-951. PubMed ID: 30694527
[TBL] [Abstract][Full Text] [Related]
4. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.
Palculict TB; Ruteshouser EC; Fan Y; Wang W; Strong L; Huff V
J Med Genet; 2016 Jun; 53(6):385-8. PubMed ID: 26566882
[TBL] [Abstract][Full Text] [Related]
5. Identification of new Wilms tumour predisposition genes: an exome sequencing study.
Mahamdallie S; Yost S; Poyastro-Pearson E; Holt E; Zachariou A; Seal S; Elliott A; Clarke M; Warren-Perry M; Hanks S; Anderson J; Bomken S; Cole T; Farah R; Furtwaengler R; Glaser A; Grundy R; Hayden J; Lowis S; Millot F; Nicholson J; Ronghe M; Skeen J; Williams D; Yeomanson D; Ruark E; Rahman N
Lancet Child Adolesc Health; 2019 May; 3(5):322-331. PubMed ID: 30885698
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.
Halliday BJ; Fukuzawa R; Markie DM; Grundy RG; Ludgate JL; Black MA; Skeen JE; Weeks RJ; Catchpoole DR; Roberts AGK; Reeve AE; Morison IM
PLoS Genet; 2018 Jun; 14(6):e1007399. PubMed ID: 29912901
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the transcriptional repressor REST predispose to Wilms tumor.
Mahamdallie SS; Hanks S; Karlin KL; Zachariou A; Perdeaux ER; Ruark E; Shaw CA; Renwick A; Ramsay E; Yost S; Elliott A; Birch J; Capra M; Gray J; Hale J; Kingston J; Levitt G; McLean T; Sheridan E; Renwick A; Seal S; Stiller C; Sebire N; Westbrook TF; Rahman N
Nat Genet; 2015 Dec; 47(12):1471-4. PubMed ID: 26551668
[TBL] [Abstract][Full Text] [Related]
8. WTX mutations can occur both early and late in the pathogenesis of Wilms tumour.
Fukuzawa R; Holman SK; Chow CW; Savarirayan R; Reeve AE; Robertson SP
J Med Genet; 2010 Nov; 47(11):791-4. PubMed ID: 20679664
[TBL] [Abstract][Full Text] [Related]
9. A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
Varley JM; McGown G; Thorncroft M; White GR; Tricker KJ; Kelsey AM; Birch JM; Evans DG
Br J Cancer; 1998 Oct; 78(8):1081-3. PubMed ID: 9792154
[TBL] [Abstract][Full Text] [Related]
10. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.
O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B
Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
12. Drosophila CG2469 Encodes a Homolog of Human CTR9 and Is Essential for Development.
Chaturvedi D; Inaba M; Scoggin S; Buszczak M
G3 (Bethesda); 2016 Dec; 6(12):3849-3857. PubMed ID: 27678520
[TBL] [Abstract][Full Text] [Related]
13. Role of the WT1 gene in Wilms' tumour.
Haber DA; Housman DE
Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
[TBL] [Abstract][Full Text] [Related]
14. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
15. A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.
Abbaszadeh F; Barker KT; McConville C; Scott RH; Rahman N
Fam Cancer; 2010 Sep; 9(3):425-30. PubMed ID: 20054657
[TBL] [Abstract][Full Text] [Related]
16. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.
Simms LA; Algar EM; Smith PJ
Eur J Cancer; 1995 Dec; 31A(13-14):2270-6. PubMed ID: 8652255
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.
Perotti D; De Vecchi G; Testi MA; Lualdi E; Modena P; Mondini P; Ravagnani F; Collini P; Di Renzo F; Spreafico F; Terenziani M; Sozzi G; Fossati-Bellani F; Radice P
Hum Mutat; 2004 Nov; 24(5):400-7. PubMed ID: 15459955
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
Baird PN; Pritchard J; Cowell JK
Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
[TBL] [Abstract][Full Text] [Related]
19. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
20. Multiple mechanisms of MYCN dysregulation in Wilms tumour.
Williams RD; Chagtai T; Alcaide-German M; Apps J; Wegert J; Popov S; Vujanic G; van Tinteren H; van den Heuvel-Eibrink MM; Kool M; de Kraker J; Gisselsson D; Graf N; Gessler M; Pritchard-Jones K
Oncotarget; 2015 Mar; 6(9):7232-43. PubMed ID: 25749049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
